相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study
Diana J. Moke et al.
LANCET CHILD & ADOLESCENT HEALTH (2021)
Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients
Zulfan Zazuli et al.
FRONTIERS IN PHARMACOLOGY (2020)
Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer
Kelly R. McMahon et al.
JAMA NETWORK OPEN (2020)
Cisplatin-Associated Nephrotoxic Effects in Children
Shveta S. Motwani et al.
JAMA NETWORK OPEN (2020)
The Impact of Genetic Polymorphisms in Organic Cation Transporters on Renal Drug Disposition
Zulfan Zazuli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prevalence of acute kidney injury after liver transplantation in children:Comparison of the pRIFLE, AKIN, and KDIGO criteria using corrected serum creatinine
Elhanan Nahum et al.
JOURNAL OF CRITICAL CARE (2019)
Outcome Definition Influences the Relationship between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients
Zulfan Zazuli et al.
GENES (2019)
Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database
Reo Tanoshima et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Biomarkers of Drug-Induced Kidney Toxicity
Benjamin R. Griffin et al.
THERAPEUTIC DRUG MONITORING (2019)
Identifying cisplatin-induced kidney damage in paediatric oncology patients
Chris D. Barton et al.
PEDIATRIC NEPHROLOGY (2018)
Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance
Roderick Skinner
PEDIATRIC NEPHROLOGY (2018)
Cisplatin-induced nephrotoxicity in patients with advanced neuroblastoma
Ryu Yanagisawa et al.
PEDIATRIC BLOOD & CANCER (2018)
Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study
Kelly R. McMahon et al.
PEDIATRIC NEPHROLOGY (2018)
Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
Zulfan Zazuli et al.
FRONTIERS IN PHARMACOLOGY (2018)
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Bryan Oronsky et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?
Antonio Ruggiero et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients
T. Powrozek et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
AKI in Hospitalized Children: Comparing the pRIFLE, AKIN, and KDIGO Definitions
Scott M. Sutherland et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Phenotype standardization for drug-induced kidney disease
Ravindra L. Mehta et al.
KIDNEY INTERNATIONAL (2015)
Cisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors A Retrospective Cohort Study
Climaco Andres Jimenez-Triana et al.
MEDICINE (2015)
Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation
Malvika H. Solanki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer
Sebastiaan L. Knijnenburg et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Germline Genetic Polymorphisms May Influence Chemotherapy Response and Disease Outcome in Osteosarcoma
Rachael E. Windsor et al.
CANCER (2012)
Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events
Kazufumi Iwata et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Association between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated with Chemotherapy
Ling Zhang et al.
PLOS ONE (2012)
Chapter 1: Definition and classification of CKD
Kidney International Supplements (2012)
An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity
Penelope D. Sanchez-Gonzalez et al.
CRITICAL REVIEWS IN TOXICOLOGY (2011)
Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect of ERCC1 polymorphisms
Mladen V. Tzvetkov et al.
PHARMACOGENOMICS (2011)
Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients
A. V. Khrunin et al.
PHARMACOGENOMICS JOURNAL (2010)
Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
K. K. Filipski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
Roderick Skinner et al.
EUROPEAN JOURNAL OF CANCER (2009)
New Equations to Estimate GFR in Children with CKD
George J. Schwartz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals
B. C. Carleton et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Renal Late Effects in Patients Treated for Cancer in Childhood: A Report From the Children's Oncology Group
Deborah P. Jones et al.
PEDIATRIC BLOOD & CANCER (2008)
Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group
Mouro O'Leary et al.
SEMINARS IN ONCOLOGY (2008)
Modified RIFLE criteria in critically ill children with acute kidney injury
A. Akcan-Arikan et al.
KIDNEY INTERNATIONAL (2007)
Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer
JA Gietema et al.
LANCET (2000)
分享论文
